Positive effects of COVID-19 control measures on influenza prevention

Positive effects of COVID-19 control measures on influenza prevention

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become a pandemic threat to the whole world. At the same time, influenza virus has been active, with influenza virus and SARS-CoV-2 sharing the same transmission routes. This article ai...

Full description

Bibliographic Details
Main Authors:	Di Wu, Jianyun Lu, Yanhui Liu, Zhoubin Zhang, Lei Luo
Format:	Article
Language:	English
Published:	Elsevier 2020-06-01
Series:	International Journal of Infectious Diseases
Subjects:	COVID-19 SARS-CoV-2 Influenza Control
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971220302253

Similar Items

Beneficial and Detrimental Effects of Cytokines during Influenza and COVID-19
by: De Chang, et al.
Published: (2024-02-01)

The potential efficacy of influenza vaccines in prevention from cardiovascular complications of COVID-19
by: MOEIN ZANGIABADIAN, et al.
Published: (2020-12-01)

Influenza vaccine compatibility among hospitalized patients during and after the COVID-19 pandemic
by: Ilana S. Fratty, et al.
Published: (2024-01-01)

Comparative Epidemiological and Clinical Outcomes on COVID-19 and Seasonal Influenza Hospitalized Patients during 2023
by: Constantin-Marinel Vlase, et al.
Published: (2024-08-01)

From COVID-19 to Influenza—Real-Life Clinical Practice in a Pediatric Hospital
by: Victor Daniel Miron, et al.
Published: (2022-05-01)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
by: Zeinab Abdelrahman, et al.
Published: (2020-09-01)

Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line
by: Alexander A. Dolskiy, et al.
Published: (2020-12-01)

Comparison of inflammatory markers, coagulation indicators and outcomes between influenza and COVID-19 infection amongst children: A systematic review and meta-analysis
by: Yutang Yang, et al.
Published: (2024-05-01)

Influenza and COVID-19 co-infection and vaccine effectiveness against severe cases: a mathematical modeling study
by: Jingyi Liang, et al.
Published: (2024-03-01)

Comparison of post-acute sequelae following hospitalization for COVID-19 and influenza
by: Ting-Hui Liu, et al.
Published: (2023-12-01)

Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China
by: Xiangsha Kong, et al.
Published: (2021-06-01)

Foreword: Prevention of COVID-19, Influenza, and Respiratory Syncytial Virus in At-Risk Populations
by: Stefan Gravenstein
Published: (2024-12-01)

A Comparative Systematic Review of COVID-19 and Influenza
by: Molka Osman, et al.
Published: (2021-03-01)

Resurgence of Influenza Circulation in the Russian Federation during the Delta and Omicron COVID-19 Era
by: Anna Sominina, et al.
Published: (2022-08-01)

Human Respiratory Infections in Nigeria: Influenza and the Emergence of SARS-CoV-2 Pandemic
by: Dennis Kabantiyok, et al.
Published: (2022-09-01)

Co-circulation and co-infection of COVID-19 and influenza in China: challenges and implications
by: Qingchun Pan, et al.
Published: (2023-12-01)

Evaluation of the Effect of Influenza Vaccine on the Development of Symptoms in SARS-CoV-2 Infection and Outcome in Patients Hospitalized due to COVID-19
by: Jose Roberto Gutierrez-Camacho, et al.
Published: (2024-07-01)

Predictors of seasonal influenza and COVID-19 vaccination coverage among adults in Tennessee during the COVID-19 pandemic
by: J. Cunningham-Erves, et al.
Published: (2024-03-01)

A decavalent composite mRNA vaccine against both influenza and COVID-19
by: Yang Wang, et al.
Published: (2024-09-01)

Optimized quantification of intra-host viral diversity in SARS-CoV-2 and influenza virus sequence data
by: A. E. Roder, et al.
Published: (2023-08-01)

Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responsesResearch in context
by: David Pattinson, et al.
Published: (2024-05-01)

Prior Influenza Infection Mitigates SARS-CoV-2 Disease in Syrian Hamsters
by: Caterina Di Pietro, et al.
Published: (2024-02-01)

The Initial COVID-19 Reliable Interactive DNA Methylation Markers and Biological Implications
by: Zhengjun Zhang
Published: (2024-04-01)

Development of specific immunity in laboratory animals after co-immunization against seasonal influenza and COVID-19
by: G. M. Ignatyev, et al.
Published: (2022-01-01)

Co-infection with SARS-CoV-2 and influenza A virus
by: Shuhei Azekawa, et al.
Published: (2020-01-01)

Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD
by: Yulei Li, et al.
Published: (2023-12-01)

Vaccine Preparedness for the Next Influenza Pandemic: A Regulatory Perspective
by: Norman W. Baylor, et al.
Published: (2022-12-01)

The Impact of COVID-19 Interventions on Influenza and Mycobacterium Tuberculosis Infection
by: Yiman Geng, et al.
Published: (2021-05-01)

Intensive care unit-acquired infections more common in patients with COVID-19 than with influenza
by: Josefine Beck-Friis, et al.
Published: (2024-07-01)

Post-viral symptoms and conditions are more frequent in COVID-19 than influenza, but not more persistent
by: Falko Tesch, et al.
Published: (2024-10-01)

Influenza vs. COVID-19: Comparison of Clinical Characteristics and Outcomes in Pediatric Patients in Mexico City
by: Almudena Laris-González, et al.
Published: (2021-06-01)

Influenza viral infection is a risk factor for severe illness in COVID-19 patients: a nationwide population-based cohort study
by: Jeong-Hwan Hwang, et al.
Published: (2023-12-01)

Was the Reduction in Seasonal Influenza Transmission during 2020 Attributable to Non-Pharmaceutical Interventions to Contain Coronavirus Disease 2019 (COVID-19) in Japan?
by: Keita Wagatsuma, et al.
Published: (2022-06-01)

A case series of coinfection with SARS-CoV-2 and influenza virus in Louisiana
by: Jennifer L. Miatech, et al.
Published: (2020-01-01)

Comparison of COVID-19 and Influenza-Related Outcomes in the United States during Fall–Winter 2022–2023: A Cross-Sectional Retrospective Study
by: Hagit Kopel, et al.
Published: (2024-01-01)

Antiviral susceptibility of SARS-CoV-2 and influenza viruses from 3 co-infected pediatric patients
by: Emi Takashita, et al.
Published: (2024-09-01)

Platelet-driven coagulopathy in COVID-19 patients: in comparison to seasonal influenza cases
by: Jianguo Zhang, et al.
Published: (2021-05-01)

Computational and Transcriptome Analyses Revealed Preferential Induction of Chemotaxis and Lipid Synthesis by SARS-CoV-2
by: Hibah Shaath, et al.
Published: (2020-09-01)

SARS-CoV-2 and Influenza Vaccines in People with Excessive Body Mass—A Narrative Review
by: Julia Drożdżyńska, et al.
Published: (2022-10-01)

Assessing the impact of COVID-19 interventions on influenza-like illness in Beijing and Hong Kong: an observational and modeling study
by: Xingxing Zhang, et al.
Published: (2023-02-01)